#United States #Boston #Clinical Trials #Lindus Health #Fierce CRO

Lindus Health: A Leader in Clinical Trial Recruitment

Lindus Health, known for its groundbreaking work in the clinical trials space, has recently been awarded the prestigious 2025 Fierce CRO Award in the category of Outstanding Patient Recruitment and Retention. This honor is a testament to the company’s innovative strategies and commitment to enhancing the efficiency and reliability of clinical trials.

The Fierce CRO Awards celebrate remarkable achievements in the field, particularly by Contract Research Organizations (CROs) that demonstrate exceptional performance and leadership in advancing life sciences research. Lindus Health earned this recognition through its unique approach known as the Patient Identification Center (PIC) technique. This method leverages advanced algorithms and tailored search protocols derived from real-world medical data, significantly lowering screen fail rates and expediting the recruitment process with heightened accuracy.

A notable achievement for Lindus was its collaboration with Myota on a pre-diabetes trial, which recorded an astounding 54% screening conversion rate—five times the industry standard—and completed its enrollment phase in just four months. This striking efficiency is a direct result of Lindus Health’s profound expertise in healthcare data, clinical systems, and physician behavior.

What sets Lindus Health apart is its distinctive methodology in conducting participant searches. Unlike many CROs that depend on generic queries run by medical practices, Lindus develops proprietary and highly customized search strategies in-house. These searches are carefully crafted, extending beyond mere inclusion and exclusion criteria and incorporating a fine-tuned comprehension of how medical information is recorded by general practitioners. For instance, in trials concerning